Sarah James Analyst PerformanceManaging Director, Equity Analyst-Healthcare Services and HCIT at Cantor FitzgeraldSarah James is a stock analyst at Cantor Fitzgerald in the medical sector, covering 22 publicly traded companies. Over the past year, Sarah James has issued 61 stock ratings, including buy and hold recommendations. While full access to Sarah James' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sarah James' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings84 Last 11 YearsBuy Recommendations56.94% 41 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution72RatingsDistribution of strong buy, buy, hold, and sell ratings by Sarah James.RatingPercentageCount Strong Buy0.0%0 ratings Buy56.9%41 ratings Hold41.7%30 ratings Sell1.4%1 ratingsOut of 72 total stock ratings issued by Sarah James at Cantor Fitzgerald, the majority (56.9%) have been Buy recommendations, followed by 41.7% Hold and 1.4% Sell.Best & Worst CallsBest Call000.0%THCFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CNCJan 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE54.5% of companies on NYSE12 companiesNASDAQ45.5% of companies on NASDAQ10 companiesSarah James, an analyst at Cantor Fitzgerald, currently covers 22 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical22 companies100.0%Sarah James of Cantor Fitzgerald specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMEDICAL SERVICES7 companies31.8%MED - HMO5 companies22.7%MED - HOSPITALS5 companies22.7%MEDICAL INFO SYS3 companies13.6%MED - BIOMED/GENE1 company4.5%MED - OUTP/HM CRE1 company4.5% Sarah James' Ratings History at Cantor Fitzgerald Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMOHMolina Healthcare5/11/2026Boost Price Target$187.47$209.00Neutral$0.0000.00% ROIDCGODocGo5/11/2026Reiterated Rating$0.57Overweight$0.0000.00% ROIHCATHealth Catalyst5/11/2026Reiterated Rating$1.49Neutral$0.0000.00% ROICICigna Group5/1/2026Boost Price Target$284.08$340.00Overweight$0.0000.00% ROICICigna Group5/1/2026Set Price Target$283.31$340.00$0.0000.00% ROIACHCAcadia Healthcare5/1/2026Boost Price Target$26.11$30.00Neutral$0.0000.00% ROIUHSUniversal Health Services4/29/2026Lower Price Target$167.81$194.00Neutral$0.0000.00% ROICNCCentene4/29/2026Set Price Target$49.42$60.00$0.0000.00% ROICNCCentene4/28/2026Upgrade$49.42$60.00Overweight$0.0000.00% ROITBRGTruBridge4/23/2026Downgrade$25.76$26.25Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. NYXHNyxoah3/23/2026Reiterated Rating$3.08$11.00Overweight$0.0000.00% ROIDCGODocGo3/17/2026Reiterated Rating$0.65$3.00Overweight$0.0000.00% ROIHCATHealth Catalyst3/13/2026Set Price Target$1.79$3.00$0.0000.00% ROIHCATHealth Catalyst3/13/2026Lower Price Target$1.24$3.00Neutral$0.0000.00% ROISGRYSurgery Partners3/4/2026Reiterated Rating$14.38Overweight$0.0000.00% ROIHCAHCA Healthcare3/4/2026Reiterated Rating$545.71Overweight$0.0000.00% ROITHCTenet Healthcare3/4/2026Reiterated Rating$245.26Overweight$0.0000.00% ROIUHSUniversal Health Services2/27/2026Lower Price Target$206.40$229.00Neutral$0.0000.00% ROIACHCAcadia Healthcare2/26/2026Reiterated Rating$22.24$25.00Outperform$0.0000.00% ROIMDXGMiMedx Group2/17/2026Lower Price Target$5.12$8.00Overweight$0.0000.00% ROIHUMHumana2/13/2026Lower Price Target$183.92$230.00Outperform$0.0000.00% ROIHUMHumana2/12/2026Set Price Target$178.67$201.00$0.0000.00% ROIHUMHumana2/12/2026Lower Price Target$174.21$201.00Neutral$0.0000.00% ROIMOHMolina Healthcare2/9/2026Lower Price Target$131.78$144.00Neutral$0.0000.00% ROICNCCentene2/9/2026Reiterated Rating$38.46$41.00Neutral$0.0000.00% ROIHCAHCA Healthcare1/28/2026Boost Price Target$506.29$588.00Overweight$0.0000.00% ROICVSCVS Health12/10/2025Reiterated Rating$78.31Overweight$0.0000.00% ROIACHCAcadia Healthcare12/3/2025Set Price Target$14.12$17.00$0.0000.00% ROIACHCAcadia Healthcare12/3/2025Lower Price Target$16.49$17.00Neutral$0.0000.00% ROIACHCAcadia Healthcare12/3/2025Set Price Target$14.40$17.00$0.0000.00% ROIACHCAcadia Healthcare11/7/2025Lower Price Target$20.26$22.00Neutral$0.0000.00% ROIACHCAcadia Healthcare11/7/2025Set Price Target$19.65$22.00$0.0000.00% ROICICigna Group10/31/2025Lower Price Target$244.67$325.00$0.0000.00% ROICNCCentene10/30/2025Boost Price Target$36.05$41.00Neutral$0.0000.00% ROICVSCVS Health10/30/2025Boost Price Target$77.28$95.00Overweight$0.0000.00% ROITHCTenet Healthcare10/29/2025Set Price Target$208.11$245.00$0.0000.00% ROITHCTenet Healthcare10/29/2025Boost Price Target$204.50$245.00Overweight$0.0000.00% ROIUHSUniversal Health Services10/29/2025Boost Price Target$224.89$250.00Neutral$0.0000.00% ROIHCAHCA Healthcare10/27/2025Reiterated Rating$446.58Overweight$0.0000.00% ROIHCAHCA Healthcare10/27/2025Set Price Target$453.93$525.00$0.0000.00% ROISpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.See how to get positioned in SpaceX before the announcement goes publicMOHMolina Healthcare10/24/2025Lower Price Target$165.14$180.00Neutral$0.0000.00% ROISGRYSurgery Partners10/7/2025Reiterated Rating$20.39$36.00Overweight$0.0000.00% ROIHCATHealth Catalyst10/7/2025Reiterated Rating$2.96$4.00Neutral$0.0000.00% ROIHCAHCA Healthcare10/7/2025Reiterated Rating$433.83$444.00Overweight$0.0000.00% ROIACHCAcadia Healthcare10/7/2025Reiterated Rating$26.46$25.00Neutral$0.0000.00% ROIUHSUniversal Health Services10/7/2025Reiterated Rating$209.67$227.00Neutral$0.0000.00% ROITHCTenet Healthcare10/7/2025Reiterated Rating$199.86$190.00Overweight$0.0000.00% ROICVSCVS Health8/26/2025Reiterated Rating$71.22$78.00Overweight$0.0000.00% ROICNCCentene8/26/2025Reiterated Rating$29.07$38.00Neutral$0.0000.00% ROICICigna Group8/26/2025Reiterated Rating$300.83$365.00Overweight$0.0000.00% ROIUNHUnitedHealth Group8/26/2025Reiterated Rating$305.29$440.00Overweight$0.0000.00% ROIUHSUniversal Health Services8/26/2025Reiterated Rating$183.43$227.00Neutral$0.0000.00% ROITHCTenet Healthcare8/26/2025Reiterated Rating$180.15$190.00Overweight$0.0000.00% ROIMOHMolina Healthcare8/26/2025Reiterated Rating$174.36$210.00Neutral$0.0000.00% ROIHCAHCA Healthcare8/26/2025Reiterated Rating$401.14$444.00Overweight$0.0000.00% ROIPGNYProgyny8/8/2025Set Price Target$22.20$28.00$0.0000.00% ROIHCATHealth Catalyst8/8/2025Reiterated Rating$3.69$4.00Neutral$0.0000.00% ROIPGNYProgyny8/8/2025Reiterated Rating$21.92$28.00Overweight$0.0000.00% ROICNCCentene7/28/2025Downgrade$28.36$38.00Neutral$0.0000.00% ROIMOHMolina Healthcare7/25/2025Reiterated Rating$164.12$210.00Neutral$0.0000.00% ROICNCCentene7/2/2025Lower Price Target$56.68$65.00Overweight$0.0000.00% ROIHUMHumana5/1/2025Reiterated Rating$259.24$290.00Neutral$000.0000.00% ROIELVElevance Health4/23/2025Reiterated Rating$430.63$485.00Overweight$000.0000.00% ROICICigna Group3/20/2025Boost Price Target$321.50$365.00Overweight$000.0000.00% ROITBRGTruBridge3/11/2025Boost Price Target$31.13$29.00Overweight$00.0000.00% ROILFMDLifeMD3/11/2025Reiterated Rating$5.37$15.00Overweight$0.0000.00% ROITHCTenet Healthcare2/13/2025Reiterated Rating$129.23$177.00Overweight$000.0000.00% ROIHUMHumana2/12/2025Reiterated Rating$261.46$290.00Neutral$000.0000.00% ROICICigna Group1/31/2025Lower Price Target$296.64$350.00Overweight$000.0000.00% ROIHCAHCA Healthcare1/27/2025Reiterated Rating$312.51$405.00Overweight$000.0000.00% ROIELVElevance Health1/24/2025Reiterated Rating$398.75$485.00Overweight$000.0000.00% ROIUNHUnitedHealth Group1/17/2025Reiterated Rating$512.05$700.00Overweight$000.0000.00% ROIELVElevance Health10/18/2024Set Price Target$432.33$485.00$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageMorgan StanleyJefferies Financial GroupStifel NicolausOppenheimerBerenberg BankRoth MkmWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD Cowen Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
